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Quality Control by Isoleucyl-tRNA 
Synthetase of Bacillus subtilis Is 
Required for Efficient Sporulation
Elizabeth Kermgard1,†, Zhou Yang1, Annika-Marisa Michel1,2,*, Rachel Simari3,*, 
Jacqueline Wong1,*, Michael Ibba3,4,5 & Beth A. Lazazzera1,6
Isoleucyl-tRNA synthetase (IleRS) is an aminoacyl-tRNA synthetase whose essential function is 
to aminoacylate tRNAIle with isoleucine. Like some other aminoacyl-tRNA synthetases, IleRS can 
mischarge tRNAIle and correct this misacylation through a separate post-transfer editing function. To 
explore the biological significance of this editing function, we created a ileS(T233P) mutant of Bacillus 
subtilis that allows tRNAIle mischarging while retaining wild-type Ile-tRNAIle synthesis activity. As 
seen in other species defective for aminoacylation quality control, the growth rate of the ileS(T233P) 
strain was not significantly different from wild-type. When the ileS(T233P) strain was assessed for its 
ability to promote distinct phenotypes in response to starvation, the ileS(T233P) strain was observed 
to exhibit a significant defect in formation of environmentally resistant spores. The sporulation defect 
ranged from 3-fold to 30-fold and was due to a delay in activation of early sporulation genes. The loss 
of aminoacylation quality control in the ileS(T233P) strain resulted in the inability to compete with a 
wild-type strain under selective conditions that required sporulation. These data show that the quality 
control function of IleRS is required in B. subtilis for efficient sporulation and suggests that editing 
by aminoacyl-tRNA synthetases may be important for survival under starvation/nutrient limitation 
conditions.
An essential step for the accuracy of mRNA translation is the charging of tRNAs with their cognate amino acid. 
Aminoacyl-tRNA synthetases (aaRS) are the enzymes that catalyze this reaction, and are a family of ancient pro-
teins that have been conserved throughout evolution, due to their essential cellular function1. AaRSs aminoac-
ylate tRNAs through a two-step mechanism: 1) formation of an aminoacyl-adenylate (e.g. Ile-AMP by IleRS), 
and 2) aminoacylation of tRNA (e.g. Ile-tRNAIle). Due to the need for accuracy in protein synthesis, some aaRSs 
contain a quality control (QC) function along with their aminoacylation function2. QC functions can hydrolyze 
either the aminoacyl-adenylate (pre-transfer editing) or the aminoacyl bond of charged tRNA (post-transfer edit-
ing). While aaRS editing functions are highly conserved in bacteria, archaea, and eukaryotes, QC is not essential 
for cellular growth under most laboratory conditions, and few studies have identified cellular functions that rely 
on aaRS editing3–7.
Isoleucine-tRNA synthetase (IleRS) possesses QC functions that discriminate between isoleucine, the 
non-cognate amino acid valine, and the non-proteinogenic amino acids, norvaline, a byproduct of branched-chain 
amino acid synthesis, and homocysteine (Hcy), a by-product from degradation of S-adenosylhomocysteine by 
LuxS in bacteria8. The aminoacylation site of IleRS is only able to discriminate Ile from Val with an accuracy of 
~1/2009. IleRS improves this accuracy with two QC activities, pre- and post-transfer editing. Pre-transfer editing 
hydrolyzes Val-AMP in the synthetic site where aminoacylation also occurs10,11, and pre-transfer editing simi-
larly hydrolyzes Hcy-AMP12. Post-transfer editing in contrast deacylates Val-tRNAIle in a domain, the connective 
peptide 1 (CP1) domain, which is distinct from the site at which aminoacylation occurs13–16. Several studies have 
1Department of Microbiology, Immunology and Molecular Genetics University of California, Los Angeles, California 
90095, USA. 2Technische Universität Braunschweig, Institut of Microbiology, Braunschweig, Germany. 3Ohio State 
Biochemistry Program, Ohio State University, Columbus, Ohio 43210, USA. 4Department of Microbiology, Ohio State 
University, Columbus, Ohio 43210, USA. 5Center for RNA Biology, Ohio State University, Columbus, Ohio 43210, 
USA. 6Molecular Biology Institute, University of California, Los Angeles, California 90095, USA. †Present Address: 
Saint Louis University School of Medicine, Saint Louis, MO 63104,USA. *These authors contributed equally to this 
work. Correspondence and requests for materials should be addressed to B.A.L. (email: BethL@microbio.ucla.edu)
received: 11 October 2016
Accepted: 22 December 2016
Published: 31 January 2017
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7:41763 | DOI: 10.1038/srep41763
identified substitutions in CP1 that disrupt post-transfer editing, but retain close to wild-type levels of aminoac-
ylation activity13,14,17.
In vivo studies of IleRS mutants have begun to reveal potential cellular functions of QC by aaRSs. One primary 
function of quality control is to prevent misincorporation in proteins of the non-cognate and non-proteinogenic 
amino acids, such as valine and norvaline, respectively. Loss of IleRS QC in E. coli results in decreased growth 
when the cells are grown in high concentrations of valine or norvaline18. The E. coli IleRS QC mutant strain is also 
more sensitive to stressful conditions, including high temperatures and antibiotics, although the mechanism by 
which these mutant cells increase their sensitivity to stress is unknown19. Loss of quality control by IleRS may also 
be beneficial under certain conditions. In E. coli and Acinetobacter baylyi, loss of IleRS QC functions resulted in 
an improved growth rate when concentrations of isoleucine were limiting, but moderate concentrations of valine 
or norvaline were present18,20. Streptococcus pneumoniae IleRS naturally lacks a post-transfer editing function, 
and mischarged tRNAIle serves as a substrate for peptidoglycan biosynthesis21. Potentially beneficial is the higher 
level of mutations observed in colonies of E. coli IleRS QC-defective cells that are allowed to age; the full mech-
anism by which DNA mutations arise in response to loss of quality control is also unknown22. Overall, while a 
number of phenotypes have been described for QC mutants, the mechanism underlying the observed changes 
and their broader importance remain unknown.
To address the question of what conditions require quality control for fitness, we choose to address how loss of 
QC by IleRS affects the function of the model Gram-positive organism, Bacillus subtilis. Here, we show that QC 
by IleRS is required for B. subtilis, to form environmentally-resistant endospores. These endospores are formed 
in response to starvation through a developmental process. This process is initiated by a master regulator, Spo0A, 
and gene expression activated by this transcription factor is severely delayed in cells that lacking QC by IleRS. 
Furthermore, the QC-defective IleRS strain was outcompeted by wild-type strains under conditions involving 
periodic sporulation and outgrowth, supporting a general role for quality control by aaRS under starvation or 
nutrient-limited conditions.
Results
Cell expressing IleRS(T233P) are defective for quality control of mischarged tRNAIle. IleRS was 
chosen for this study as it has a well characterized post-transfer editing activity, and substitutions that disrupt 
this editing without affecting aminoacylation have been made10,11,23. While several studies have looked at the 
role of QC by IleRS in E. coli, relatively few studies have examined the importance of QC in other organisms. As 
we had previously proposed that QC maybe more critical under conditions of stress that limit cellular growth3, 
we chose to analyze the role of QC by IleRS in B. subtilis, which undergoes several distinct phenotypic or devel-
opmental shifts in response to starvation or slow growth, including the formation of environmentally-resistant 
endospores24.
To determine the function of QC by IleRS in B. subtilis, a single point mutation was introduced into the ileS 
gene on the chromosome of B. subtilis strain JH64225. The point mutation introduced causes a substitution of Thr 
at codon 233 to Pro. This T233P substitution was chosen because a similar substitution in IleRS of Escherichia coli 
was shown to disrupt QC by this enzyme, and while other substitutions in E. coli IleRS disrupt QC, the T233P 
substitution has virtually no effect on aminoacylation activity14,23. To test whether the cells with the ileS(T233P) 
allele lacked tRNAIle QC activity, cell lysates of the wild-type ileS and mutant ileS(T233P) were tested for their 
ability to charge tRNAIle with either the cognate Ile or the non-cognate amino acids, Val and Leu. Lysates from 
the ileS(T233P) strain showed Ile-tRNAIle production at a similar rate as lysates from wild-type cells (Fig. 1A), 
indicating that the ileS(T233P) mutation did not affect the overall level of Ile-tRNAIle formation in cells. Similarly, 
the ileS(T233P) lysate showed only low levels of Leu-tRNAIle production, similar to that seen with lysates from 
wild-type cells, and consistent with the Leu not being an aminoacylation substrate for either wild-type IleRS or 
IleRS(T233P) (Fig. 1C). Production of Val-tRNAIle however was significantly different between wild-type and 
Figure 1. The ileS(T233P) strain mischarges tRNAIle with valine. Cell extracts of BAL4574 (WT; filled 
squares) and BAL4571(ileS(T233P); open circles) were assayed for their ability to aminoacylate tRNAIle with 
14C versions of isoleucine (A), valine (B), or leucine (C). Plotted is the average pmoles of the radiolabeled tRNA 
from three reactions versus the time after the addition of tRNAIle and the radiolabeled amino acid. Error bars 
are standard error of the mean. Lines are best fits of the data to a Michaelis-Menton equation, with the exception 
of WT in panels B and C, as the basal level of aminoacylation observed could not be fit.
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ileS(T233P) cell lysates, with the ileS(T233P) lysate producing significantly more Val-tRNAIle than the wild-type 
lysate (Fig. 1B). Increased Val-tRNAIle synthesis for IleRS(T233P) may either indicate improved Val recognition 
and/or reduced hydrolysis of either misactivated Val-AMP or mischarged Val-tRNAIle compared with wild-type. 
Importantly, whatever the precise mechanism by which the T233P substitution increased Val-tRNAIle synthesis, 
this did not adversely affect the ability of cells to aminoacylate tRNAIle with its cognate amino acid and did disrupt 
QC by IleRS.
Cells expressing IleRS(T233P) are defective in sporulation. Having created a mutant strain of 
B. subtilis that expresses an QC-defective version of IleRS, we sought to determine whether ileS(T233P) cells had 
any phenotypic differences from wild-type. Any phenotypes altered in these mutant cells would suggest pathways 
that are sensitive to QC by IleRS. The exponential growth rate (∆ Ln OD600/∆ time(min) ± standard deviation) in 
rich medium, Difco Sporulation Medium (DSM), of wild-type cells and cells expressing IleRS(T233P) were not 
significantly different (0.020 ± 0.002 and 0.021 ± 0.002, respectively). Similarly, in minimal medium, the expo-
nential growth rate of these two strains was also not significantly different (0.011 ± 0.002 for wild-type cells and 
0.010 ± 0.003 for the ileS(T233P) cells). These data are consistent with other observations of QC-defective aaRS 
bacterial strains are not affected for growth under standard laboratory conditions3.
As the editing function of IleRS is conserved through evolution3, and cells in natural environments are char-
acterized by slow growth, the wild-type and ileS(T233P) mutant B. subtilis cells were assessed for their ability to 
form biofilms and spores, two major phenotypic states entered by this bacterium under slow-growth conditions26. 
While wild strains of B. subtilis form more robust biofilms, laboratory strain JH642 used in this study is able 
to form biofilms that adhere to the wells of a microtiter plate and to form flat, unstructured pellicle biofilms at 
air-liquid interfaces27–30. Both the ileS(T233P) strain and its isogenic wild-type strain formed morphologically 
indistinguishable pellicles that were observed as films of cells at the top of media in test tubes. In microtiter plates, 
there was at best a small difference in how the two strains adhered to the plates, and the A570 ± standard deviation 
was 1.4 ± 0.3 for the wild-type strain and 0.87 ± 0.02 for the ileS(T233P) strain. These data support a conclusion 
that the QC by IleRS is not essential for biofilm formation, although we cannot rule out a more prominent role for 
editing in wild strains of B. subtilis.
To assess the ability of the ileS(T233P) mutant cells to sporulate, these cells and the isogenic wild-type control 
cells were grown in DSM and incubated until sixteen hours after entry into stationary phase. At this time, the 
frequency of sporulation was determined as the number of heat-resistant colony-forming units (CFU)/ml relative 
to the total viable CFU/ml (Table 1). While the fold difference in the sporulation frequency of wild-type and the 
ileS(T233P) cells was variable, ranging from 1.5- to 15-fold, the ileS(T233P) cells showed a statistically significant 
(p = 0.015) defect in sporulation. The variability in the sporulation phenotype is not unexpected given the sto-
chasticity in frequency of mischarging of a tRNA.
To determine whether this sporulation defect was specific to growth in DSM, cells were grown in minimal 
media containing 0.1% glucose. Cells in this media exhaust glucose and transition to stationary phase at an OD600 
of ~1.0. After 16 hours in stationary phase, the frequency of sporulation was assayed (Table 1). Similar to DSM 
conditions, the ileS(T233P) mutant exhibited a statistically significant (p > 0.001) defect in sporulation, except 
that the ileS(T233P) cells showed a larger defect in sporulation, ranging from a 4- to 30-fold defect.
The ileS(T233P) mutant is outcompeted by wild-type cells during cycles of sporulation. To 
assess the importance of the QC function of IleRS for B. subtilis, we asked how well the ileS(T233P) mutant was 
able to compete with the wild-type strain. We introduced into the wild-type and ileS(T233P) strains either a 
thrC::erm allele that encodes erythromycin resistance (ErmR) or a thrC::cat allele that encodes chloramphenicol 
resistance (CmR). Cultures were inoculated with an equal mixture of both wild-type and ileS(T233P) cells of dif-
ferent antibiotic-resistance markers. In the repeats of the cultures, the antibiotic-resistance markers were swapped 
between the two strains to ensure that any differences observed were due to the presence of the ileS(T233P) 
mutation. The cultures were grown in DSM and passaged through a cycle of exponential growth, sporulation, and 
Trial
Wild-Type IleRS (T233P)
Viablea Sporesb Frequencyc Viablea Sporesb Frequencyc
Difco Sporulation Media
 1 5.9 × 108 3.5 × 108 60% 3.6 × 108 1.3 × 108 35%
 2 6.8 × 108 3.8 × 108 56% 3.5 × 108 1.2 × 108 34%
 3 4.9 × 108 3.8 × 108 78% 3.2 × 108 1.6 × 107 5%
 4 4.6 × 108 3.6 × 108 77% 6.0 × 108 7.1 × 107 12%
 5 3.4 × 108 3.5 × 108 100% 3.5 × 108 2.5 × 107 71%
Glucose Minimal Media
 1 2.7 × 108 1.8 × 108 67% 1.6 × 108 3.4 × 106 2.1%
 2 2.7 × 108 2.3 × 108 85% 1.8 × 108 1.3 × 107 7.2%
 3 9.1 × 107 9.2 × 107 100% 1.1 × 108 3.1 × 107 27%
Table 1.  Sporulation Frequency of Wild-Type and IleRS(T233P) Cells. aReported are the CFU/ml of the 
cultures after 16 hours of incubation in stationary phase. bAfter testing for viable cells, the cultures were heat 
treated at 80 °C for 20 minutes and then plated for CFU/ml counts. cThe frequency of sporulation was calculated 
as [(spores CFU/ml)/(viable CFU/ml)*100].
www.nature.com/scientificreports/
4Scientific RepoRts | 7:41763 | DOI: 10.1038/srep41763
heat-kill of non-sporulated cells. A 1/10th fraction of the spores that remained after the heat-kill step were used 
to inoculate the next culture that was similarly passaged through a cycle of exponential growth, sporulation, and 
heat-kill of non-sporulated cells. This was repeated for a total of four cycles. At the end of each cycle, the percent 
of the spores that were from wild-type and ileS(T233P) cells was measured through CmR and ErmR CFU/ml, as 
appropriate. For each independent culture started, there was a similar number of cells of each strain at the end of 
the first passage, consistent with no significant differences in the growth rate of these two strains. Subsequently, 
the number of ileS(T233P) cells dropped relative to the number of wild-type cells by the second or third pas-
sage, with the level of ileS(T233P) mutant after the fourth passage being 105-fold lower than wild-type (Fig. 2). 
Interestingly, under these competition experiments, the ileS(T233P) mutant consistently showed a greater that 
10-fold defect in sporulation (Fig. 2), unlike what was observed for this strain when grown individually (Table 1). 
These data predict that the ileS(T233P) mutant would go to extinction after five cycles and strongly suggests that 
sporulation is one of the evolutionary pressures maintaining the QC function of IleRS in B. subtilis.
The QC-defective IleRS mutant is defective in expressing genes activated by the master regulator 
of sporulation, Spo0A. A major question from this work is why sporulation is sensitive to mistakes made by 
IleRS. The process of sporulation can be divided into distinct genetic and morphological stages31. The sporulation 
defect of the ileS(T233P) could stem from mistranslation of Ile codons, which could result in a non-functional 
protein that is required for sporulation. If a particular protein is negatively affected in the ileS(T233P) strain, we 
would predict the ileS(T233P) cells to be specifically delayed at one stage of sporulation, resulting in a strong 
reduction in expression of those stage-specific genes. However, mistranslation is predicted to happen randomly 
at Ile codons, with each cell having a different mixture of mistranslated proteins, and as a result each cell in a 
population could be delayed at a different stage in sporulation, and we would not observe a strong effect on any 
particular stage-specific gene expression at the population level.
To determine whether there is a strong decrease in stage-specific sporulation gene expression in the 
ileS(T233P) mutant, we monitored gene expression of Spo0A-controlled genes. Spo0A is the first transcription 
factor to become active, through phosphorylation by a phosphorelay, in the sporulation regulatory cascade32, 
and if Spo0A-dependent genes have strongly reduced expression, then all subsequent stage-specific sporulation 
genes will also have reduced expression. One of the operons activated by Spo0A is spoIIE, which encodes the 
phosphatase required for activation of the forespore specific sigma factor, Sigma-F33. Thus, we introduced into 
our isogenic wild-type and ileS(T233P) mutant a spoIIE-lacZ fusion. Cells were grown in DSM, and samples were 
collected for ß-galactosidase assay at time points just prior to and for several hours after the entry into stationary 
phase. As seen in Fig. 3A, while wild-type cells induced spoIIE expression one hour after entry into stationary 
phase, spoIIE expression was delayed in the ileS(T233P) cells for five hours, after which point spoIIE is induced. 
This late induction of spoIIE expression in the ileS(T233P) mutant may explain why sporulation does occur in the 
mutant, albeit at a lower efficiency than wild-type cells.
Altered spoIIE expression in the ileS(T233P) mutant strain strongly suggests that Spo0A activity is reduced 
in this mutant strain. To confirm this, we assessed expression of a second Spo0A-activated promoter, spoIIG, as 
Figure 2. The ileS(T233P) strain is outcompeted by wild-type cells. Derivatives of BAL4574 (WT; circles) 
and BAL4571 (ileS(T233P); squares), which carried either erythromycin-resistant or chloramphenicol-resistant 
genes, were mixed in equal numbers in DSM and incubated until 16 hours post the onset of stationary phase. At 
that time, the total CFU/ml (open symbols) was assessed for both cell types. The cultures were then heated to 
kill vegetative cells, and the CFU/ml of spores (filled symbols) was assessed for both cell types. A 1/10th volume 
of the spores was then transferred to a new DSM culture, and the process was repeated for four days. Plotted is 
the average CFU/ml of four separate cultures versus the day of the competition. Error bars are standard error of 
the mean.
www.nature.com/scientificreports/
5Scientific RepoRts | 7:41763 | DOI: 10.1038/srep41763
a lacZ fusion34. The spoIIG operon encodes the mother cell-specific sigma factor, sigma-E35. Similar to what was 
seen with spoIIE expression, expression of spoIIG was defective for several hours after entry into sporulation in 
the ileS(T233P) strain (Fig. 3B), confirming the general defect in Spo0A-controlled gene expression.
Discussion
Here, we present the first strain of B. subtilis to lack QC for a mischarged tRNA, specifically tRNAIle. This strain 
has a point mutation in the endogenous copy of ileS, and whole cell extracts of this mutant strain mischarged 
tRNAIle with valine unlike the wild-type strain. While this QC-defective strain showed no defect in exponential 
growth, it has a significantly reduced ability to sporulate. The sporulation defect of the QC-defective IleRS strain 
appears to be due to weak and/or delayed activation of the first transcription factor in the sporulation cascade, 
Spo0A. Competition through periods of exponential growth, sporulation, and lethal challenge reveal that the 
ileS(T233P) strain was rapidly outcompeted by the wild-type strain, suggesting that starvation conditions that 
induce sporulation have selected for the maintenance of the IleRS QC function in B. subtilis.
The loss of QC by IleRS in B. subtilis leads to a delay in expression of sporulation genes controlled by Spo0A, 
the first transcription factor that is activated in the sporulation cascade. Spo0A also regulates genes involved in 
other processes including biofilm formation26, but the ileS(T233P) strain exhibited a less than two-fold defect in 
the ability to form biofilms, much smaller than the defect observed for sporulation. Phosphorylation of Spo0A 
is the rate-limited step for the initiation of sporulation36,37, and expression of sporulation genes requires a higher 
Figure 3. Expression of a Spo0A-activated gene is delayed in the ileS(T233P) mutant. Strains carrying a 
spoIIE-lacZ (A) or spoIIG-lacZ (B) fusion were grown in DSM. Samples were removed periodically, and the 
ß-galactosidase specific activity ((Δ A420 per minute per ml of culture per OD600) × 1000) was measured and 
plotted versus the time the sample was harvested relative to the time at which stationary phase for the culture 
commenced. The strains grown in panel A were BAL4575 (WT; closed squares) and BAL4576 (ileS(T233P); 
open circles), and strains grown in panel B were BAL4418 (WT; closed squares) and BAL4419 (ileS(T233P); 
open circles). The data shown are representative of at least three independent experiments.
www.nature.com/scientificreports/
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level of phosphorylated Spo0A than biofilm genes38,39, suggesting that the ileS(T233P) strain may be defective in 
forming high levels of phosphorylated Spo0A. Spo0A is activated by phosphorylation through a phosphorelay40, 
and there are several known negative regulators of this phosphorelay. Future research will address what step along 
this Spo0A activation pathway is affected in the ileS(T233P) mutant or whether there is a Spo0A-independent 
mechanism that is affecting the expression of these spoII genes. Understanding how B. subtilis controls spor-
ulation has allowed researchers to identify how cells sense cell cycle problems, which are amplified by check-
points that delay sporulation, including DNA replication, chromosome partitioning, and tricarboycylic cycle 
metabolism41,42, and research into how loss of QC by IleRS affects sporulation could reveal a novel checkpoint. 
It is not known at this time if the requirement of QC for sporulation is specific to IleRS or whether loss of QC 
by other aaRSs will similarly disrupt sporulation in B. subtilis. Intriguingly, the ileS gene of B. subtilis and other 
endospore-forming species is adjacent to a gene, ylyA, required for spore germination43.
What causes sporulation to be so sensitive to the loss of QC by IleRS? IleRS could encounter conditions that 
promote a higher rate of mischarging of tRNAIle in stationary phase, through a higher ratio of non-cognate Val 
to cognate Ile. Alternatively, the rate of mischarging, and subsequent mistranslation, may be identical between 
exponential growth and stationary phase, and a protein(s) involved in sporulation may be particularly sensitive 
to mistranslation. A further possibility is that there is a higher ratio of charged to uncharged tRNAIle as a result 
of loss of QC by IleRS, and this altered ratio may delay activation of the sporulation pathway. E. coli cells express-
ing an editing-defective form of the phenylalanine tRNA synthetase (PheRS), have a higher ratio of charged to 
uncharged tRNAPhe under amino acid starvation and are unable to mount a stringent response44. In B. subtilis, the 
stringent response is induced by uncharged tRNAs and has been shown to activate sporulation45. The higher ratio 
of charged to uncharged tRNAIle in B. subtilis may also affect the putative ILE-T-Box (i.e. riboswitch) of ileS, which 
could alter the levels of IleRS and possibly exacerbate the problems caused by loss of QC46,47. Biosynthesis of Ile 
and other branched-chain amino acids (BCAA) is not predicted to be directly affected in the IleRS QC-defective 
mutant, as aaRS are highly specific for their cognate tRNA and the BCAA biosynthesis operon ilvBHC-leuABCD 
is controlled by tRNALeu and a LEU-T-Box48. Future experiments to address the potential models outlined here 
for why quality control by IleRS is critical for sporulation, but not exponential growth, will require measuring cel-
lular amino acid pools, the level of the stringent response alarmone, ppGpp, mistranslation, and charged tRNAIle 
in actively growing and sporulating cells.
Sporulation by B. subtilis is a developmental process induced by starvation, specifically limitation for carbon, 
nitrogen, or phosphorous49–51, and it is the major state in which B. subtilis is isolated from the environment52. 
Cells lacking QC by IleRS are rapidly outcompeted by wild-type cells under conditions requiring sporulation, 
which strongly argues that sporulation is the physiological condition that selects for the maintenance of QC by 
IleRS in B. subtilis. These data further suggest that the primary role of QC by IleRS in other species, and possibly 
QC by other aaRSs, may be in allowing survival of cells that have a severely reduced growth rate. Consistent with 
this, QC by alanine tRNA synthetase (AlaRS) was shown to be required in terminally differentiated mouse neu-
ronal cells and cardiomyocytes, non-growing or slowly-growing cell populations5,53. Intriguingly, QC by some 
aaRSs has been lost from mitochondria and Mycoplasma species, many of which are intracellular parasites54–57. 
This latter finding suggests that, in the absence of changing environmental conditions, QC by aaRSs may not be 
required and is consistent with the suggestion of the work presented here that QC is required by cells that must 
transition from rapid growth to slow-growth/stationary phase induced by nutrient limitation.
In summary, we have shown for the first time that the quality control function of a tRNA synthetase is critical 
for sporulation in B. subtilis. The IleRS QC was required for activating the genes controlled by the master tran-
scription factor, Spo0A, and cells lacking IleRS QC were rapidly lost from a mixed population when a selection 
for sporulation was applied. These data suggest that the QC function of tRNA synthetases may be conserved to 
deal with particular stress conditions that are encountered by cells as their growth slows or they enter stationary 
phase in response to nutrient limitation.
Experimental Procedures. tRNA Preparation. Bacillus subtilis tRNAIle was transcribed in vitro as previ-
ously described58.
Cell Free Extract Preparation. B. subtilis tRNA-free cell free extracts were prepared as described59, using strains 
containing either a wild-type ileS gene or an editing deficient allele of ileS (ileS(T233P)), except EDTA-free pro-
tease inhibitor (Roche) was used during lysis to replace PMSF. Briefly, the supernatant following ultracentrifuga-
tion was loaded onto DEAE Sephacel (GE) resin. Cell free extracts were quantified using a BCA Protein Assay kit 
(Thermo Scientific Pierce).
Aminoacylation Assays. Aminoacylation assays using cell free extracts of wild-type ileS and ileS(T233P) strains 
were performed as previously described21. Each reaction contained 450 μ g extract protein, 1070 ng/μ L of B. sub-
tilis tRNAIle, 0.1 mM cognate [14C]Ile at 200 cpm/pmol (Moravek Biochemicals), 0.15 mM non-cognate [14C]Val 
at 120 cpm/pmol (PerkinElmer), and 0.3 mM non-cognate [14C]Leu at 120 cpm/pmol (Moravek Biochemicals).
Growth conditions. E. coli and B. subtilis strains were routinely grown in Luria-Bertani (LB) medium. For sporu-
lation assays, B. subtilis strains were grown in either Difco sporulation medium (DSM)60 or S750 minimal medium 
with 0.1% glucose61. Both E. coli and B. subtilis strains were grown at 37 °C. Antibiotics were used as required 
at the following concentrations: ampicillin 100 μ g/ml, chloramphenicol 5 μ g/ml, erythromycin 0.5 μ g/ml, and 
tetracycline 12.5 μ g/ml. The growth rate was measured as the slope of the line from the natural log of the OD600 
readings versus the time of incubation in minutes. Only points in exponential growth were used for a line fit, and 
only line fits that gave an R-value greater than 0.99 were considered valid.
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Strain construction. E. coli strain Top10 (Invitrogen) was used for the routine construction and maintenance of 
plasmids. The B. subtilis strains used in this study are all derivatives of the JH642 strain, which contains the trpC2 
and pheA1 mutations25 and were constructed by transformation of genetically competent cells with chromosomal 
DNA or plasmids using standard protocols60. Gene replacement was verified using PCR.
The B. subtilis ileS(T233P) strain was constructed by transformation with a plasmid, pBL4566, containing 
the ileS(T233P) gene. The pBL4566 plasmid is a derivative of pJet1.2 (Thermo Fisher) that contains a restric-
tion site for the I-SceI meganuclease62 and the cat gene for chloramphenicol resistance. The ileS gene was PCR 
amplified with primers ileS-F (5′ -GCATGGATCCAAGGAATAAATTCTCTGATTA) and ileS-R (5′ - GCA 
TAGATCTGCATATCGGTCAACTGAACGC) and ligated to pJet1.2 according to the instructions of the CloneJET 
PCR Cloning Kit (ThermoFisher Scientific). An I-SceI-cat cassette was constructed by PCR amplification with 
pJH10163 as a template and primers I-SceI-cat-A ( 5′ - AT GC C TG CA G T AG GG AT AA CA GG GT AA T TA TT 
 GG GC GC TC TT CC GC T AA GCATGCGTTACCCTTATTATCAAGA) and I-SecI-cat-B (5′  -ATGC 
CTGCAGGCGAGTCAGTGAGCGAGGAAGCAAGCATGCGGAGCTGTAATATAAAAAC), in which the 
underlined sequence corresponds to the cat gene, the I-SecI site is bold, and PstI restriction sites are italicized. 
Both the I-SceI-cat PCR and the pJet1.2-ileS plasmid were digested with PstI and ligated, to yield a 
pJet-ileS-I-SceI-cat plasmid. This plasmid was subjected to site-directed mutagenesis using primers T233P-F 
(5′ - GCATCATCATTTGGACACCAACGCCGTGGACAATT) and its reverse complement (the bold, under-
lined nucleotide is the introduced mutation), according to directions of Quikchange Lightning Site-Directed 
Mutagenesis Kit (Agilent Technologies). The presence of the mutation was confirmed by DNA sequencing, and 
the resulting plasmid was named pBL4566.
To transfer the ileS(T233P) allele on pBL4566 to the chromosome of B. subtilis, a wild-type strain of B. subtilis, 
JH64225, was transformed with pBL4566, and transformants were selected on plates containing chloramphenicol. 
The resulting strain, BL4568, which has pBL4566 integrated into its chromosome at the ileS locus, has two alleles 
of ileS, one wild-type and one ileS(T233P), flanking the pJet1.2 plasmid backbone and the I-Sce1-cat cassette. 
To return the chromosome to just one copy of ileS and remove the pBL4566 plasmid, the pBKJ223 plasmid that 
expresses the I-Sce1 meganuclease64 was transformed into BAL4568, and transformants were selected on plates 
containing tetracycline. I-Sce1 cleaves the chromosome at the I-SceI restriction site on the pBL4566 plasmid, 
and repair of this DNA break by homologous recombination results in a strain that has removed the plasmid 
sequences and restored the native ileS chromosomal structure, with the ileS allele present being either wild-type 
or ileS(T233P). To screen for cells that have lost the plasmid sequence, transformants were screened for chlo-
ramphenicol sensitivity. The ileS allele present in the chloramphenicol-sensitive clones were screened by PCR 
amplification and DNA sequencing, including the genes to either side of ileS, ylyA and divIVA. One strain with 
the ileS(T233P) allele and one with the wild-type ileS allele were selected. To remove pBKJ223 from the desired 
clones, cells were grown in LB liquid cultures lacking antibiotic selection. Colonies from these cultures were 
streak-purified on LB agar plates and then screened for tetracycline sensitivity. Two tetracycline-sensitive clones, 
one wild-type ileS and one ileS(T233P), were named BAL4574 and BAL4571, respectively. To assay expression 
of sporulation genes, thrC::(spoIIE-lacZ, erm)65,66 and Spß::(spoIIG-lacZ, cat)67 were introduced into BAL4574 
(wild-type) and BAL4571 (ileS(T233P)).
Sporulation Assays. To assess the ileS(T233P) mutant for sporulation, strains were assessed for the presence of 
heat-resistant spores, as previously described60. Briefly, cells were grown in liquid Difco Sporulation Medium 
(DSM) until 16 hours after the onset of stationary phase. At this time, the total viable CFU/ml was measured and 
then the cultures were heated at 80 °C for 20 minutes, and the heat-resistant CFU/ml was measured as the number 
of spores present.
β-Galactosidase Assays. Cells were grown as described above for sporulation assays, except that samples were 
harvested throughout the exponential growth phase and several hours past the entry of the cultures into station-
ary phase. The cells were then harvested by centrifugation, and resuspended in Z-Buffer, and ß-galactosidase 
activity was measured as previously described68. β -galactosidase-specific activity is presented as (Δ A420 per min-
ute per ml of culture per OD600) × 1000).
Biofilm formation Assays. Cells were grown for 24 hours in polyvinyl chloride microtiter plates in Biofilm 
Growth Medium, a modified LB based medium supplemented with 124 mM potassium phosphate pH 7.0, 15 mM 
ammonium sulphate, 3.4 mM sodium citrate, 0.01 mM MgSO4, and 0.1% glucose as previously described28–30. 
After incubation, the wells were washed twice and subsequently stained with crystal violet. The wells were rinsed 
to remove any non-adherent crystal violet and treated with a solubilizing solution of 80% ethanol, 20% acetic 
acid; the A570 of the solution was then measured. The A570 of 16–24 wells were averaged. When the SEM (standard 
error of the mean) of the A570 measurements obtained for the 16–24 wells was < 10% of the mean, the assay was 
considered valid. Each assay was repeated on at least three independent occasions, and the averages from all valid 
assays were averaged to determine the level of biofilm formation for a strain.
Growth of pellicle biofilms. Bacterial cells were inoculated at OD600 0.025 into Biofilm Growth Medium and 
grown with shaking until OD600 ~1.0. The cells were diluted into fresh Biofilm Growth Medium to an OD600 of 
0.01 and 5 ml were added to culture test tubes. The tubes were incubated at 37 °C for 48 hours with no shaking, at 
which times the pellicles were imaged.
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